Adjuvant therapy with immuno-modulators în oncology

Abstract

In the field of oncology immunotherapy, remarkable discoveries have been made în in recent years. The aim of this paper is to cover recent findings în oncology immunotherapy, including the use of inhibitory T cells, modified T cells, anti-cancer vaccines, and anti-B and T antibodies. In veterinary oncology, immunotherapy is increasingly used due to impressive results. Modified T-cell therapy has demonstrated remarkable tumor control and regression în human subjects, and anticancer vaccines have recently demonstrated long disease-free periods and increased survival time în dogs with lymphoma. Thus, due to the clinical effects obtained, immunomodulators are successfully used în veterinary oncology therapy.